1. Home
  2. TSHA vs GIC Comparison

TSHA vs GIC Comparison

Compare TSHA & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • GIC
  • Stock Information
  • Founded
  • TSHA 2019
  • GIC 1949
  • Country
  • TSHA United States
  • GIC United States
  • Employees
  • TSHA N/A
  • GIC N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • GIC Industrial Machinery/Components
  • Sector
  • TSHA Health Care
  • GIC Industrials
  • Exchange
  • TSHA Nasdaq
  • GIC Nasdaq
  • Market Cap
  • TSHA 728.4M
  • GIC 860.9M
  • IPO Year
  • TSHA 2020
  • GIC 1995
  • Fundamental
  • Price
  • TSHA $2.32
  • GIC $28.09
  • Analyst Decision
  • TSHA Strong Buy
  • GIC
  • Analyst Count
  • TSHA 5
  • GIC 0
  • Target Price
  • TSHA $8.20
  • GIC N/A
  • AVG Volume (30 Days)
  • TSHA 3.7M
  • GIC 79.5K
  • Earning Date
  • TSHA 08-11-2025
  • GIC 07-29-2025
  • Dividend Yield
  • TSHA N/A
  • GIC 3.85%
  • EPS Growth
  • TSHA N/A
  • GIC N/A
  • EPS
  • TSHA N/A
  • GIC 1.59
  • Revenue
  • TSHA $7,224,000.00
  • GIC $1,313,500,000.00
  • Revenue This Year
  • TSHA N/A
  • GIC $4.19
  • Revenue Next Year
  • TSHA N/A
  • GIC $4.08
  • P/E Ratio
  • TSHA N/A
  • GIC $17.09
  • Revenue Growth
  • TSHA N/A
  • GIC N/A
  • 52 Week Low
  • TSHA $1.05
  • GIC $20.79
  • 52 Week High
  • TSHA $3.31
  • GIC $36.17
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 41.03
  • GIC 54.27
  • Support Level
  • TSHA $2.29
  • GIC $26.85
  • Resistance Level
  • TSHA $2.48
  • GIC $27.85
  • Average True Range (ATR)
  • TSHA 0.17
  • GIC 0.51
  • MACD
  • TSHA -0.05
  • GIC -0.05
  • Stochastic Oscillator
  • TSHA 9.21
  • GIC 53.59

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

Share on Social Networks: